TIDM0QCV TIDM0Y7T 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               AbbVie Inc. 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.01 common stock 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                30(th) March 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                68,307,682  4.62578% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  68,307,682  4.62578% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                            52,300                    74.61 
--------------  -----------------------------  ----------------------- 
   Purchase                                60                    74.65 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,900                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                             5,100                    74.72 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                             5,000                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,558                    73.95 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,400                    74.61 
--------------  -----------------------------  ----------------------- 
   Purchase                            53,340                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                            17,780                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                            19,880                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                               864                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,235                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                             4,400                    75.24 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,000                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                               1,512                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 300                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                               1,900                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 300                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 300                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 464                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 800                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                               8,478                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                               1,872                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                               2,504                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 969                    75.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 253                    75.24 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                     NO 
-------------------------------------------------------  ----------------- 
Date of disclosure                                       31(th) March 2020 
-------------------------------------------------------  ----------------- 
Contact name                                               Lionel Colaco 
-------------------------------------------------------  ----------------- 
Telephone number                                              020 33956098 
-------------------------------------------------------  ----------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ----------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ----------------- 
 
 
 
 
 
 

(END) Dow Jones Newswires

March 31, 2020 10:41 ET (14:41 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From May 2020 to Jun 2020 Click Here for more Allergan Charts.
Allergan (NYSE:AGN)
Historical Stock Chart
From Jun 2019 to Jun 2020 Click Here for more Allergan Charts.